|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bellissimo F, Pinzone MR, Cacopardo B and
Nunnari G: Diagnostic and therapeutic management of hepatocellular
carcinoma. World J Gastroenterol. 21:12003–12021. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goh GB, Chang PE and Tan CK: Changing
epidemiology of hepatocellular carcinoma in Asia. Best Pract Res
Clin Gastroenterol. 29:919–928. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dutta R and Mahato RI: Recent advances in
hepatocellular carcinoma therapy. Pharmacol Ther. 173:106–117.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Z, Tu K and Liu Q: Effects of
microRNA-30a on migration, invasion and prognosis of hepatocellular
carcinoma. FEBS Lett. 588:3089–3097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li C, Chen J, Zhang K, Feng B, Wang R and
Chen L: Progress and prospects of long noncoding RNAs (lncRNAs) in
hepatocellular carcinoma. Cell Physiol Biochem. 36:423–434. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Makita Y, Murata S, Katou Y, Kikuchi K,
Uejima H, Teratani M, Hoashi Y, Kenjo E, Matsumoto S, Nogami M, et
al: Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model
mice of hepatocellular carcinoma. Biochem Biophys Res Commun.
493:800–806. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ciechanover A: The ubiquitin-proteasome
proteolytic pathway. Cell. 79:13–21. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eletr ZM and Wilkinson KD: Regulation of
proteolysis by human deubiquitinating enzymes. Biochim Biophys
Acta. 1843:114–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sato Y, Yamagata A, Goto-Ito S, Kubota K,
Miyamoto R, Nakada S and Fukai S: Molecular basis of Lys-63-linked
polyubiquitination inhibition by the interaction between human
deubiquitinating enzyme OTUB1 and ubiquitin-conjugating enzyme
UBC13. J Biol Chem. 287:25860–25868. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Reyes-Turcu FE and Wilkinson KD:
Polyubiquitin binding and disassembly by deubiquitinating enzymes.
Chem Rev. 109:1495–1508. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Youle RJ and van der Bliek AM:
Mitochondrial fission, fusion, and stress. Science. 337:1062–1065.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Komander D, Clague MJ and Urbé S: Breaking
the chains: Structure and function of the deubiquitinases. Nat Rev
Mol Cell Biol. 10:550–563. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
McClurg UL, Summerscales EE, Harle VJ,
Gaughan L and Robson CN: Deubiquitinating enzyme Usp12 regulates
the interaction between the androgen receptor and the Akt pathway.
Oncotarget. 5:7081–7092. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Burska UL, Harle VJ, Coffey K, Darby S,
Ramsey H, O'Neill D, Logan IR, Gaughan L and Robson CN:
Deubiquitinating enzyme Usp12 is a novel co-activator of the
androgen receptor. J Biol Chem. 288:32641–32650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei R, Liu X, Yu W, Yang T, Cai W, Liu J,
Huang X, Xu GT, Zhao S, Yang J and Liu S: Deubiquitinases in
cancer. Oncotarget. 6:12872–12889. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stewart ZA and Pietenpol JA: Cell cycle
checkpoints as therapeutic targets. J Mammary Gland Biol Neoplasia.
4:389–400. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Medema RH and Macůrek L: Checkpoint
control and cancer. Oncogene. 31:2601–2613. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li F, Huang J, Ji D, Meng Q, Wang C, Chen
S, Wang X, Zhu Z, Jiang C, Shi Y, et al: Utility of urinary
circulating tumor DNA for EGFR mutation detection in different
stages of non-small cell lung cancer patients. Clin Transl Oncol.
19:1283–1291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu Q, Li L, Han C, Wei L, Kong L and Lin
F: Sigma-1 receptor (σ1R) is downregulated in hepatic malignant
tumors and regulates HepG2 cell proliferation, migration and
apoptosis. Oncol Rep. 39:1405–1413. 2018.PubMed/NCBI
|
|
21
|
Yuan X, Sun X, Shi X, Jiang C, Yu D, Zhang
W, Guan W, Zhou J, Wu Y, Qiu Y and Ding Y: USP39 promotes the
growth of human hepatocellular carcinoma in vitro and in
vivo. Oncol Rep. 34:823–832. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nagappan A, Lee WS, Yun JW, Lu JN, Chang
SH, Jeong JH, Kim GS, Jung JM and Hong SC: Tetraarsenic hexoxide
induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt
suppression and p38 MAPK activation in SW620 human colon cancer
cells. PLoS One. 12:e01745912017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun XT, Yuan XW, Zhu HT, Deng ZM, Yu DC,
Zhou X and Ding YT: Endothelial precursor cells promote
angiogenesis in hepatocellular carcinoma. World J Gastroenterol.
18:4925–4933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hegele A, Kamburov A, Grossmann A, Sourlis
C, Wowro S, Weimann M, Will CL, Pena V, Lührmann R and Stelzl U:
Dynamic protein-protein interaction wiring of the human
spliceosome. Mol Cell. 45:567–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang LJ, Li Y, Liu YL, Wang JM, Liu DW and
Tian QB: USP12 regulates cell cycle progression by involving c-Myc,
cyclin D2 and BMI-1. Gene. 578:92–99. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bulavin DV, Higashimoto Y, Popoff IJ,
Gaarde WA, Basrur V, Potapova O, Appella E and Fornace AJ Jr:
Initiation of a G2/M checkpoint after ultraviolet radiation
requires p38 kinase. Nature. 411:102–107. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tarn C, Zou L, Hullinger RL and Andrisani
OM: Hepatitis B virus X protein activates the p38 mitogen-activated
protein kinase pathway in dedifferentiated hepatocytes. J Virol.
76:9763–9772. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang Q, Liu X, Wu Y, Liao Y, Huang Y, Wei
X and Ma M: P38 MAPK pathway mediates cognitive damage in
pentylenetetrazole-induced epilepsy via apoptosis cascade. Epilepsy
Res. 133:89–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu G, Qiu W, Li Y, Zhao C, He F, Zhou M,
Wang L, Zhao D, Lu Y, Zhang J, et al: Sublytic C5b-9 induces
glomerular mesangial cell apoptosis through the cascade pathway of
MEKK2-p38 MAPK-IRF-1-TRADD-caspase 8 in rat Thy-1 nephritis. J
Immunol. 198:1104–1118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang HL, Hsieh MJ, Chien MH, Chen HY,
Yang SF and Hsiao PC: Glabridin mediate caspases activation and
induces apoptosis through JNK1/2 and p38 MAPK pathway in human
promyelocytic leukemia cells. PLoS One. 9:e989432014. View Article : Google Scholar : PubMed/NCBI
|
